BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 31328113)

  • 1. Health Benefits of Carotenoids: A Role of Carotenoids in the Prevention of Non-Alcoholic Fatty Liver Disease.
    Lee Y; Hu S; Park YK; Lee JY
    Prev Nutr Food Sci; 2019 Jun; 24(2):103-113. PubMed ID: 31328113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Potential of Non-Provitamin A Carotenoids for the Prevention and Treatment of Non-Alcoholic Fatty Liver Disease.
    Murillo AG; DiMarco DM; Fernandez ML
    Biology (Basel); 2016 Nov; 5(4):. PubMed ID: 27834813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carotenoids and fatty liver disease: Current knowledge and research gaps.
    Clugston RD
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Nov; 1865(11):158597. PubMed ID: 31904420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver Homeostasis.
    Ni Y; Zhuge F; Nagashimada M; Ota T
    Nutrients; 2016 Jun; 8(7):. PubMed ID: 27347998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of NAFLD/NASH by Astaxanthin and β-Cryptoxanthin.
    Ota T
    Adv Exp Med Biol; 2021; 1261():231-238. PubMed ID: 33783746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments.
    Kitade H; Chen G; Ni Y; Ota T
    Nutrients; 2017 Apr; 9(4):. PubMed ID: 28420094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carotenoids and non-alcoholic fatty liver disease.
    Yilmaz B; Sahin K; Bilen H; Bahcecioglu IH; Bilir B; Ashraf S; Halazun KJ; Kucuk O
    Hepatobiliary Surg Nutr; 2015 Jun; 4(3):161-71. PubMed ID: 26151056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary Carotenoids and Non-Alcoholic Fatty Liver Disease among US Adults, NHANES 2003⁻2014.
    Christensen K; Lawler T; Mares J
    Nutrients; 2019 May; 11(5):. PubMed ID: 31108934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutritional Importance of Carotenoids and Their Effect on Liver Health: A Review.
    Elvira-Torales LI; García-Alonso J; Periago-Castón MJ
    Antioxidants (Basel); 2019 Jul; 8(7):. PubMed ID: 31330977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease.
    Chen G; Ni Y; Nagata N; Xu L; Ota T
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27563875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease and lipotoxicity.
    Wasilewska N; Lebensztejn DM
    Clin Exp Hepatol; 2021 Mar; 7(1):1-6. PubMed ID: 34027109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herbal Medicine in the Treatment of Non-Alcoholic Fatty Liver Diseases-Efficacy, Action Mechanism, and Clinical Application.
    Xu Y; Guo W; Zhang C; Chen F; Tan HY; Li S; Wang N; Feng Y
    Front Pharmacol; 2020; 11():601. PubMed ID: 32477116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Relevance of Vitamins and Carotenoids With Liver Steatosis and Fibrosis Detected by Transient Elastography in Adults.
    Liu X; Shen H; Chen M; Shao J
    Front Nutr; 2021; 8():760985. PubMed ID: 34869532
    [No Abstract]   [Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease.
    Smith BW; Adams LA
    Crit Rev Clin Lab Sci; 2011; 48(3):97-113. PubMed ID: 21875310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review of the Effects of Fucoxanthin on NAFLD.
    Sayuti NH; Muhammad Nawawi KN; Goon JA; Mokhtar NM; Makpol S; Tan JK
    Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease.
    Perla FM; Prelati M; Lavorato M; Visicchio D; Anania C
    Children (Basel); 2017 Jun; 4(6):. PubMed ID: 28587303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventative and Therapeutic Effects of Astaxanthin on NAFLD.
    Sayuti NH; Muhammad Nawawi KN; Goon JA; Mokhtar NM; Makpol S; Tan JK
    Antioxidants (Basel); 2023 Aug; 12(8):. PubMed ID: 37627546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential depletion of carotenoids and tocopherol in liver disease.
    Leo MA; Rosman AS; Lieber CS
    Hepatology; 1993 Jun; 17(6):977-86. PubMed ID: 8514270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic steatohepatitis and hepatocellular carcinoma: implications for lycopene intervention.
    Ip BC; Wang XD
    Nutrients; 2013 Dec; 6(1):124-62. PubMed ID: 24379011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetics in non-alcoholic fatty liver disease.
    Lee J; Kim Y; Friso S; Choi SW
    Mol Aspects Med; 2017 Apr; 54():78-88. PubMed ID: 27889327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.